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Gfles de la Tourette Syndrome (TS) is a familial, 
neuropsychiatric disorder characterized by chronic, 
intermittent motor and vocal tics that typically appear in 
childhood although the clinical expression varies. Affected 
individuals may display additional symptoms, but the 
diagnosis is based on the presence of both motor and vocal 
tics. Evidence suggests that obsessive compulsive disorder 
(OCD) and chronic multiple tics (CT) alone (motor not 
vocal) can sometimes be alternate expressions of the same 
underlying disorder as TS. Attention deficit hyperactivity 
disorder (ADHD) has been thought by some researchers to 
be related to TS but this has not been clearly established. 
Research on twins and adoption studies support a genetic 
basis for the disorder. Segregation analyses of family data 
suggest that the inheritance pattern closely approximates a 
single major locus with an autosomal dominant mode of 
transmission. These analyses on different sets of families 
have given very similar results suggesting genetic 
homogeneity at least in mode of inheritance. Under the 
most likely major locus model, not all individuals carrying 
a gene for TS actually express the disorder, or at least they 
do not display symptoms that lead to a clinical diagnosis of 
TS. The probability that individuals at risk for but not 
clinically affected by the disorder have actually inherited 
the genetic predisposition is influenced by their sex and 
age. By age 21, most males have become affected if they 
are gene carriers for TS but only about 60% of female 
carriers have become affected. The pattern of symptoms 
also differs by sex. Obsessive compulsive disorder without 
TS, for instance, is more frequent in females than in males 
and appears to be an alternate expression of the disorder 
in females but not, or only rarely, in males. 
About 500 loci have been tested for genetic linkage to a 
major locus for TS in the 14 multi-generational families our 
labs have been studying. Cell lines have been established on 
312 individuals in the 4 New Haven-Rochester kindreds. 
Blood has been drawn on 385 individuals in the 10 families 
from the Netherlands and Norway collected by the 
Rotterdam group although it is only now in 1992 that 
funding has become available to establish cell lines from 
frozen lymphocytes. The Marshfield group has been 
routinely typing Dutch family 7 along with their own 
Wisconsin TS family and has also now typed one of the 
New Haven-Rochester kindreds for some microsatellite 
systems. 
No strong, positive evidence of linkage has yet been found. 
In the case of a complex disorder like TS, a lod score of 
about +5 or higher would be the minimum positive 
evidence for linkage. As the number of independent marker 
loci tested rises, the minimum acceptable lod score should 
also be increased to compensate for the number of times a 
spurious positve lod score can occur by chance. One rule of 
thumb being followed to adjust for chance data 
configurations is to add the logarithm of the number of 
independent loci tested to the minimum positive lod score 
of 3. 
Assuming the same major locus underlies the disorder in 
the different kindreds we are studying, then our pooled 
results have excluded more than 80% of the autosomal 
genome with lod scores less than -2. These exclusions are 
based on a combination of paimise and multipoint linkage 
analyses. All families have not been tested for all marker 
loci, however, and sometimes the same markers typed on 
different families have not been sufficiently informative to 
allow a useful test of linkage in all the kindreds. 
When the linkage results are examined separately by 
family, the exclusionary totals are substantially less than 
80% for each family and the particular chromosomal 
regions excluded vary across the families. If TS is 
genetically heterogeneous, then our search for linkage is not 
as far along as is implied by our pooled results. 
However, those marker loci that have been typed on 
multiple families show no evidence for genetic heterogeneity 
at present. Thus, no subset of the kindreds under study has 
given strong, positive evidence of linkage when the 
remaining kindreds provide exclusionary findings in the 
same region. 
Among the families collected for the New Haven and 
Rochester collaboration, large stretches of the genome have 
not been excluded yet on chromosomes 4, 6, 9, 11, 12, 13, 
14, 15, 16, 21, and 22. The Rotterdam study families have 
not yet excluded sizeable portions of chromosomes 1, 2, 3, 
4, 5, 6, 8, 10, 14, 17, and 20. The largest fraction of the 
genome excluded is about 45% in one of the New Haven 
study families and just over 50% in one of the Rotterdam 
study families. 
Weakly positive lod scores (lods between 1 and 2) also have 
been observed near many markers in our families. We are 
targeting these areas in selecting additional markers to 
type. 
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